ESC Premium Access

Early Rhythm-Control Therapy in Patients with Atrial Fibrillation: A nationwide cohort study

Congress Presentation

About the speaker

Doctor Tze-Fan Chao

Taipei Veterans General Hospital, Taipei (Taiwan)
4 presentations
0 follower

4 more presentations in this session

Risk of atrial fibrillation development of sodium-glucose co-transporter 2 inhibitor and thiazolidinedione treatment among patients with type 2 diabetes

Speaker: Assistant Professor Y. Kim (Gwangju, KR)


Oral anticoagulation in atrial fibrillation patients at intermediate risk of stroke: a nationwide registry-based cohort (Atrial Fibrillation in Norway - AFNOR)

Speaker: Doctor M. Anjum (Baerum, NO)


Are the results of the RATE-AF trial reproducible in daily practice? Clinical outcomes with digoxin vs beta-blocker for heart rate control in permanent atrial fibrillation

Speaker: Professor L. Fauchier (Tours, FR)


Low incidence of major complications after the first six hours post-atrial fibrillation ablation - same-day discharge safe and feasible in most patients

Speaker: Doctor A. Paul Nordin (Stockholm, SE)


Access the full session

Clinical questions: management of patients with atrial fibrillation

Speakers: Doctor T. Chao, Assistant Professor Y. Kim, Doctor M. Anjum, Professor L. Fauchier, Doctor A. Paul Nordin

About the event


ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb